Detalles de la búsqueda
1.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med
; 376(5): 417-428, 2017 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28146658
2.
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.
J Urol
; 199(2): 407-415, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28870862
3.
Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
Urol Int
; 94(4): 401-5, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25660255
4.
Trimodality therapy for bladder conservation in treatment of invasive bladder cancer.
Curr Urol Rep
; 14(2): 109-15, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23341373
5.
Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.
J Urol
; 187(2): 463-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177159
6.
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
BJU Int
; 104(2): 179-83, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19154448
7.
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
BJU Int
; 102(9 Pt B): 1345-53, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19035903
8.
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.
Eur Urol
; 72(1): 54-60, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28040351
9.
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Eur Urol
; 71(6): 952-960, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081860
10.
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
Int J Radiat Oncol Biol Phys
; 94(1): 67-74, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700703
11.
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.
Urol Oncol
; 34(10): 430.e1-7, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27381895
12.
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
J Clin Oncol
; 32(34): 3801-9, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25366678
13.
Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
Int J Radiat Oncol Biol Phys
; 86(2): 311-6, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23474117
14.
Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases.
Hum Pathol
; 44(5): 860-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23199526
15.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2003. A 33-year-old woman with gross hematuria.
N Engl J Med
; 349(25): 2442-7, 2003 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-14681511
16.
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Eur Urol
; 61(4): 705-11, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22101114
17.
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
J Clin Oncol
; 27(25): 4055-61, 2009 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19636019
18.
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Urology
; 73(4): 833-7, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19100600
19.
Bladder-sparing approaches to invasive disease.
World J Urol
; 24(5): 517-29, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17082940
20.
Surgery: selective bladder-preserving therapy for muscle-invasive cancer.
Nat Rev Clin Oncol
; 6(4): 193-4, 2009 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19333224
Resultados
1 -
20
de 20
1
Próxima >
>>